The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Bifidobacterium animalis strain DN‐173 010 shortens the colonic transit time in healthy women: a double‐blind, randomized, controlled study
Open accessAbstract
Background: A previous study has suggested that Bifidobacterium animalis DN‐173 010 shortens the colonic transit time in women. Aim: To confirm this effect and to determine whether modifications of the faecal bacterial mass and/or faecal secondary bile salts may be the explanation. Methods: A double‐blind, cross‐over study was performed. Thirty‐six healthy women were studied in four consecutive 10‐day periods. During periods 2 and 4, they ingested three 125 g cups per day of a fermented milk which was either a product containing B. animalis DN‐173 010 or a control without bifidobacteria. Periods 1 and 3 were run‐in and washout periods, respectively. The total and segmental colonic transit times were assessed using a pellet method. In 12 subjects, all stools were collected and analysed for pH, faecal weight, bacterial mass and bile acids. Results: The total and sigmoid transit times were significantly shorter during dosing with B. animalis compared to the control period. The other transit times, faecal weight, pH, bacterial mass and bile acids were not significantly affected. Conclusions: B. animalis DN‐173 010 shortens the colonic transit time in healthy women. This effect is not explained by modifications of the faecal bacterial mass or secondary bile acids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In healthy adults as well as elderly subjects, a fermented milk containing Bifidobacterium animalis DN-173 010 alone or in association with the yoghurt starters Lactobacillus bulgaricus and Streptococcus thermophilus has been shown to decrease orofecal and ⁄ or colonic, especially sigmoid, transit time; [22][23][24][25]”
From Effect of a fermented milk containing Bifidobacterium animalis DN‐173 010 on the health‐related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double‐blind, controlled trial (2007) · cites this paper as [24]
Experimental — accuracy not yet measuredIn the citing paper
“Clinical evidence of the efficacy of some probiotics in the improvement of symptoms in irritable bowel syndrome (IBS) has recently emerged (1 -3) .”
In the citing paper
“The variability of the effects reported has highlighted the product and strain specificity, which is supported by the high variability in their properties (anti-inflammatory activity, effect on motility or visceral sensation) (1,2) .”
In the citing paper
“Given the fact that alterations of gut microbiota have been identified in IBS (1,39) ,”
In the citing paper
“intervention with probiotics could be accompanied by modification of intestinal transit time as observed by Marteau et al. [26].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional food science and gastrointestinal physiology and function
Salminen, S., Bouley, C., Boutron, M.-C., Cummings, J. H., Franck, A., Gibson, G. R., Isolauri, E., Moreau, M.-C., Roberfroid, M., & Rowland, I. (1998) · British Journal of Nutrition · doi:10.1079/bjn19980108 · Cited by 1,398
Self-citationSaavedra, J. M., Bauman, N. A., Perman, J. A., Yolken, R. H., Saavedra, J. M., Bauman, N. A., & Oung, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91708-6 · Cited by 958
Isolauri, E., Juntunen, M., Rautanen, T., Sillanaukee, P., & Koivula, T. (1991) · PubMed · Cited by 684
Salminen, S. (1993) · Medical Entomology and Zoology · Cited by 659
Protection from gastrointestinal diseases with the use of probiotics
Marteau, P. R., de Vrese, M., Cellier, C., & Schrezenmeir, J. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.430s · Cited by 596
Self-citationTHE MICROBIAL CONTRIBUTION TO HUMAN FAECAL MASS
Stephen, A. M., & Cummings, J. H. (1980) · Journal of Medical Microbiology · doi:10.1099/00222615-13-1-45 · Cited by 545
The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity
Goldin, B. R., & Gorbach, S. L. (1984) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/39.5.756 · Cited by 393
Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis
Shornikova, A., Casas, I. A., Mykkänen, H. M., Salo, E., & Vesikari, T. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199712000-00002 · Cited by 319
General methods for the analysis of metabolic profiles of bile acids and related compounds in feces.
Setchell, K. D. R., Lawson, A. M., Tanida, N., & Sjövall, J. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37923-2 · Cited by 285
Screening of Lactic Acid Bacteria for Bile Salt Hydrolase Activity
Tanaka, H., Doesburg, K. K., Iwasaki, T., & Mierau, I. (1999) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(99)75506-2 · Cited by 283
Research works printed but not linked: 2
- Marteau P, 1992, Survie dans l'intestin grêle de Lactobacillus acidophilus et Bifidobacterium sp. ingérés dans un lait fermenté: une base rationnelle pour l'utilisation des probiotiques chez l'homme, Gastroenterol Clin Biol, 16, 25
- BouvierM MéanceS BouleyC BertaJL GrimaudJC.Effects of consumption of a milk fermented with the probiotic strainBifidobacterium animalisDN‐173 010 on colonic transit times in healthy humans.Biosci Microflora:in press.
Cited by
Sorted by citations
Bifidobacteria and Their Role as Members of the Human Gut Microbiota
O’Callaghan, A. A., & van Sinderen, D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00925 · Cited by 1,160
Dietary prebiotics: current status and new definition
Gibson, G. R., Scott, K. P., Rastall, R. A., Tuohy, K. M., Hotchkiss, A. T., Dubert‐Ferrandon, A., Gareau, M. G., Murphy, E. F., Saulnier, D. M. A., Loh, G., et al. (2010) · Food Science & Technology Bulletin Functional Foods · doi:10.1616/1476-2137.15880 · Cited by 820
Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits
PICARD, C., FIORAMONTI, J., FRANCOIS, A., ROBINSON, T., NEANT, F., & MATUCHANSKY, C. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02615.x · Cited by 618
McNulty, N. P., Yatsunenko, T., Hsiao, A., Faith, J. J., Muegge, B. D., Goodman, A. L., Henrissat, B., Oozeer, R., Cools-Portier, S., Gobert, G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002701 · Cited by 559
Adolfsson, O., Meydani, S. N., & Russell, R. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.2.245 · Cited by 531
Metadata
- Authors
- Marteau, P., Cuillerier, E., Meance, S., Gerhardt, M. F., Myara, A., Bouvier, M., Bouley, C., Tondu, F., Bommelaer, G., & Grimaud, J. C.
- Affiliations
- Hôpital Européen Georges-Pompidou (FR)
- Hôpital Paris Saint-Joseph (FR)
- Hôpital Nord (FR)
- Danone (France) (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- Corresponding author
- Marteau, P.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2002-03
- Volume
- 16
- Issue
- 3
- Pages
- 587-593
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2095211103
- Semantic Scholar
- 5b7ed18525ff7f83410a6fa94631c733746de855
- Cited by
- 254
- References
- 28
- Citations by year
- 2026: 3 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 9 · 2018: 6 · 2017: 15 · 2016: 9 · 2015: 8 · 2014: 20 · 2013: 19 · 2012: 12
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Alimentary Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- colonic transit time, fermented milk, probiotics, women, secondary bile acids, fecal weight, intestinal motility
- MeSH terms
- Adult, Bifidobacterium, Diet, Double-Blind Method, Feces, Female, Fermentation, Gastrointestinal Transit, Humans, Yogurt, Biomass, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
